4Rifai N, Ridker PM. Proposed cardiovascular rick assessment algorithm using high-sensitivity C-reactive protein and lipid screening [J]. Clin Chem,2001,47( 1 ) :28 -30.
5Oh SW, Moon JD, Park SY,et al. Evaluation of fluorescence of hs- CRP immunoassay for point-of-care testing [ J ]. Clini Chim Acta, 2005,365(3) :172 - 177.
6McIntosh K. Community-aquired pneumonia in children[J]. N Engl J Med, 2002,346 ( 6 ) :429 - 437.
7Bickel C, Rupprecht H J, Blankenberg S, et al. Relation of markers of inflammation ( C-reactive protein, fibrinogen, vonWillebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with ang/nograp-hieally proveneoronary artery disease[J]. Am J Cardiol,2002,89 ( 8 ) :901 - 908.
8Biasucci LM ,Liuzzo G, Grillo RL, et al. Eleavated levels of C-reactive protein at discharge in patients with unsatable angina predict recurrent instability[ J ]. Circulation, 1999, 99 (7) : 855 - 860.
